4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-016772
Chairman and CEO bought 23,750 shares at an average $1.67 ($39,734)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2020-03-03 | Purchase | +8,750 | $1.66 | $14,525 | 10,417,293 | D |
| Niihara Yutaka Chairman and CEO | 2020-03-04 | Purchase | +4,850 | $1.64 | $7,954 | 10,422,143 | D |
| Niihara Yutaka Chairman and CEO | 2020-03-05 | Purchase | +10,150 | $1.70 | $17,255 | 10,432,293 | D |
| Open-market purchases · 23,750 sh · avg $1.67 · $39,734 | |||||||
Loading xslF345X03/doc4.xml…